PDS BIOTECHNOLOGY CORPORATION - COMMON STOCK

PDS Biotech to Participate at Cantor Fitzgerald’s Oncology & HemOnc Conference

22 Sep 2022 08:00:00 By Nasdaq GlobeNewswire

PDS Biotech and National Cancer Institute Identify Optimal Patient Group for Advancing PDS0101-Based Triple Combination Program Targeting Advanced HPV-Positive Cancers

21 Sep 2022 08:00:01 By Nasdaq GlobeNewswire

PDS Biotech to Participate at H.C. Wainwright 24th Annual Global Investment Conference

06 Sep 2022 08:00:01 By Nasdaq GlobeNewswire

PDS Biotech Completes $35 Million Financing Agreement Led By Horizon Technology Finance

24 Aug 2022 16:01:00 By Nasdaq GlobeNewswire

PDS Biotech Reports Second Quarter 2022 Financial Results and Provides Business Update

08 Aug 2022 07:00:01 By Nasdaq GlobeNewswire

PDS Biotech Independent Data Monitoring Committee Recommends VERSATILE-002 Trial Continuation without Modifications

04 Aug 2022 08:00:02 By Nasdaq GlobeNewswire

PDS Biotech to Participate at BTIG Biotechnology Conference 2022

02 Aug 2022 08:00:01 By Nasdaq GlobeNewswire

PDS Biotechnology Announces Conference Call and Webcast for Second Quarter 2022 Financial Results

26 Jul 2022 08:00:01 By Nasdaq GlobeNewswire

PDS Biotechnology Announces Presentation of Universal Flu Vaccine Preclinical Data at the 41st American Society of Virology Meeting

14 Jul 2022 08:00:01 By Nasdaq GlobeNewswire

PDS Biotechnology Appoints Spencer Brown as Senior Vice President, General Counsel

03 Jun 2022 08:00:00 By Nasdaq GlobeNewswire

PDS Biotechnology Granted FDA Fast Track Designation for Lead Candidate PDS0101

02 Jun 2022 08:00:02 By Nasdaq GlobeNewswire

PDS Biotech Announces Expansion of its VERSATILE-002 Clinical Trial into Europe

31 May 2022 08:00:01 By Nasdaq GlobeNewswire

PDS Biotech Announces Presentation of Efficacy and Safety Data from VERSATILE-002 Phase 2 Clinical Trial in Recurrent or Metastatic Head and Neck Cancer at ASCO 2022

26 May 2022 17:02:00 By Nasdaq GlobeNewswire

PDS Biotech Announces Presentation of Data from NCI-Led Triple Combination Phase 2 Clinical Trial in Advanced, Refractory HPV-Positive Cancers at ASCO 2022

26 May 2022 17:01:00 By Nasdaq GlobeNewswire

PDS Biotechnology to Host Conference Call Following Poster Presentations of PDS0101 Data at 2022 ASCO Annual Meeting

25 May 2022 08:00:01 By Nasdaq GlobeNewswire

PDS Biotechnology Appoints Seasoned Business Development Executive Sanjay Zaveri as Senior Vice President, Business Development

18 May 2022 08:00:01 By Nasdaq GlobeNewswire

PDS Biotech to Participate at Upcoming Investor Conferences

17 May 2022 08:00:04 By Nasdaq GlobeNewswire

PDS Biotech Provides Business Update and Reports First Quarter 2022 Financial Results

11 May 2022 07:00:02 By Nasdaq GlobeNewswire

PDS Biotechnology Announces Conference Call and Webcast for First Quarter 2022 Financial Results

28 Apr 2022 08:00:02 By Nasdaq GlobeNewswire

PDS Biotech Announces Two Abstracts Accepted for Presentation at the 2022 American Society of Clinical Oncology Annual Meeting

27 Apr 2022 10:01:00 By Nasdaq GlobeNewswire